LIVINGSTON, N.J., May 21 /PRNewswire-FirstCall/ -- MM2 Group, Inc. (OTC Bulletin Board: MMGP) reported on May 20, 2008, in a Form 10-QSB filing with the Securities and Exchange Commission, net income of $2,019,862 for the quarter ending March 31, 2008, which is the third quarter of fiscal 2008 for the Company. In the same time period last year, the Company reported income of $254,223.
Total sales for the three months ended March 31, 2008 and 2007 were $685,663 and $247,954, respectively. The increase in sales in 2008 was derived from the sales of nutritional supplements by Genotec Nutritionals, Inc., the Company's wholly-owned subsidiary.
Total other (income) expense for the three months ended March 31, 2008 was an income of $2,169,040. This total was comprised of a gain on revaluation of derivatives of $2,711,630. This amount was offset by amortization of the discount on debt conversion of $223,344, liquidated damages of $108,275, interest expense of $47,387 and beneficial interest expense of $165,074. Loss from operations for the three months ended March 31, 2008 equaled $149,178 versus a loss of $492,597 in the same period last year.
This financial performance is a record in the history of the MM2 Group.
Mark Meller, CEO of MM2 Group, commented, "We are proud to report these results for the third quarter of 2008. The management team at Genotec Nutritionals, our wholly-owned subsidiary, is doing an excellent job of delivering great results. We look forward to continuing to deliver superior results throughout the rest of the year. Shareholders should read the complete details of our third quarter results in the Company's recently filed Form 10-QSB."
About MM2 Group, Inc.
MM2 Group is involved in the acquisition and build-out of dietary
supplement and nutraceutical companies. The Company's growth strategy is to
acquire firms in this extensive and expanding but highly fragmented segment
as it seeks to create substantia
|SOURCE MM2 Group, Inc.|
Copyright©2008 PR Newswire.
All rights reserved